Bio-Path regains Nasdaq minimum bid price compliance; delisting risk resolved

BIO-PATH HOLDINGS, INC.

Received Nasdaq letter on March 8, 2024 confirming bid price compliance.
Closing bid price at or above $1.00 for 10 consecutive days through March 7, 2024.
Nasdaq Rule 5550(a)(2) matter closed; continued listing on Nasdaq Capital Market.
No other material changes or events disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.